---
figid: PMC6555088__cvy255f3
figtitle: GSK-3 signalling in heart
organisms:
- Homo sapiens
pmcid: PMC6555088
filename: cvy255f3.jpg
figlink: /pmc/articles/PMC6555088/figure/cvy255-F3/
number: F3
caption: 'GSK-3 signalling in heart. The salient features of cardiac GSK3 signalling
  are illustrated in this schematics. The binding of growth factors to their receptors
  (e.g. Insulin) leads to activation of PI3K/Akt pathway. AKT subsequently phosphorylates
  GSK-3 and inhibits its activities. GSK-3 plays a key regulatory role in the highly
  conserved canonical Wnt signalling pathway. GSK-3 mediated phosphorylation of β-catenin
  leads to its ubiquitination and degradation by the proteasome, preventing target
  gene expression. In the absence of GSK-3, stabilized β-catenin accumulates and translocates
  to the nucleus. GSK-3 negatively regulates plethora of signalling molecules, so
  the consequences of GSK-3 inhibition are activation of these factors, including:
  (i) TGF-β1-SMAD-3 signalling, (ii) Mitochondrial mPTP pore opening, (iii) NF-AT,
  hypertrophy regulator, (iv) glycogen synthase, glycogen synthesis regulator, (v)
  mTORC1, autophagy, and metabolism regulator, (vi) D- and E-type cyclins, cell cycle
  regulator, (vii) Myc, metabolism, and proliferation regulator. p38 inhibit GSK-3
  through an alternative mechanism. GSK-3α regulates AMPK and mTOR, the master regulators
  of autophagy and metabolism. In the absence of GSK-3α, mTOR is dysregulated leading
  to impaired autophagy. GSK-3α also regulates the β-adrenergic receptor responsiveness
  and cAMP production via unknown mechanisms. In addition, GSK-3α directly interacts
  and phosphorylates cyclin E1 in CMs and its deletion promotes E2F-1 and cyclin E1
  recruitment and CM proliferation.'
papertitle: 'Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for
  in situ cardiac regeneration.'
reftext: Anand Prakash Singh, et al. Cardiovasc Res. 2019 Jan 1;115(1):20-30.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9400688
figid_alias: PMC6555088__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6555088__F3
ndex: dc2cde98-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6555088__cvy255f3.html
  '@type': Dataset
  description: 'GSK-3 signalling in heart. The salient features of cardiac GSK3 signalling
    are illustrated in this schematics. The binding of growth factors to their receptors
    (e.g. Insulin) leads to activation of PI3K/Akt pathway. AKT subsequently phosphorylates
    GSK-3 and inhibits its activities. GSK-3 plays a key regulatory role in the highly
    conserved canonical Wnt signalling pathway. GSK-3 mediated phosphorylation of
    β-catenin leads to its ubiquitination and degradation by the proteasome, preventing
    target gene expression. In the absence of GSK-3, stabilized β-catenin accumulates
    and translocates to the nucleus. GSK-3 negatively regulates plethora of signalling
    molecules, so the consequences of GSK-3 inhibition are activation of these factors,
    including: (i) TGF-β1-SMAD-3 signalling, (ii) Mitochondrial mPTP pore opening,
    (iii) NF-AT, hypertrophy regulator, (iv) glycogen synthase, glycogen synthesis
    regulator, (v) mTORC1, autophagy, and metabolism regulator, (vi) D- and E-type
    cyclins, cell cycle regulator, (vii) Myc, metabolism, and proliferation regulator.
    p38 inhibit GSK-3 through an alternative mechanism. GSK-3α regulates AMPK and
    mTOR, the master regulators of autophagy and metabolism. In the absence of GSK-3α,
    mTOR is dysregulated leading to impaired autophagy. GSK-3α also regulates the
    β-adrenergic receptor responsiveness and cAMP production via unknown mechanisms.
    In addition, GSK-3α directly interacts and phosphorylates cyclin E1 in CMs and
    its deletion promotes E2F-1 and cyclin E1 recruitment and CM proliferation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - LONP1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ILK
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PTK2
  - SMAD2
  - SMAD3
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - AKT1
  - AKT2
  - AKT3
  - SMAD4
  - APC
  - PROC
  - CP
  - CXCR1
  - SMAD6
  - GSK3A
  - GSK3B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - RHOA
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AXIN1
  - AXIN2
  - CTNNB1
  - SMAD7
  - MAP3K7
  - NR2C2
  - PDK1
  - PDPK1
  - E2F1
  - UBE2L3
  - PLN
  - PLB1
  - MTOR
  - RPTOR
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - GNAS
  - GNAL
  - RPS6KB1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - EIF4EBP1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - EIF2B1
  - EIF2B4
  - EIF2B3
  - EIF2B2
  - EIF2B5
  - EIF2S2
  - MYC
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - APC
  - MPTP
  - ischemic
  - Hypertrophic
  - cardiomyopathy
---
